GoldPFreedmanSD. Specific carcinoembryonic antigens of the human digestive system. J Exp Med1965; 122: 468–81.
2.
ThomsonDMPKrupeyJFreedmanSD. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA1969; 64: 161–7.
3.
RogersGTKeepPA. CEA-like activity in normal colon tissue. Eur J Cancer1980; 16: 127–31.
4.
KhooSKWarnerNLLieJJA quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and foetal organs. Int J Cancer1973; 11: 681–7.
5.
KeepPALeakeBARogersGT. Extraction of CEA from tumour tissue, foetal colon and patients' sera, and the effect of perchloric acid. Br J Cancer1978; 37: 171–82.
6.
GoslinRO'BrienMJSteeleGCorrelation of plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med1981; 71: 246–53.
7.
ZamcheckN.The expanding field of colorectal cancer markers: CEA, the prototype. Cancer Bull1981; 33: 141–51.
8.
LoewensteinMSZamcheckN.Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer1978; 42, Suppl. 3: 1412–18.
9.
StevensDPMackayIR. Carcinoembryonic antigen raised in heavy cigarette smokers. Lancet1973; 2: 1238–9.
10.
WaneboHJStearnsMSchwartzMK. Use of CEA as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg1978; 188: 481–93.
11.
HansenHJSnyderJJMillerECarcinoembryonic antigen (CEA). A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol1974; 5: 139–47.
12.
ChuTMMurphyGP. Carcinoembryonic antigen. New York State J Med1978; 78: 879–82.
13.
National Institutes of Health Consensus Development Conference Statement. CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer. Tumor Diagnostik1981; 2: 59–61.
14.
DilowariJBLennard-JonesJEMacKayAMEstimation of carcinoembryonic antigen in ulcerative colitis with special reference to malignant change. Gut1975; 16: 255–60.
15.
ZiegenbeinRJacobashKHPilgrimGDetermination of CEA in plasma of patients with colorectal carcinoma and polyps. Arch Geschwulstforsch1980; 50: 165–8.
16.
DoosWGWolffWIShinyaHCEA levels in patients with colorectal polyps. Cancer1975; 36: 1996–2003.
17.
HineKRLeonardJCBoothSNCarcinoembryonic antigen concentrations in undiagnosed patients. Lancet1978; 2: 1337–40.
18.
HerreraMAMingCTHolyokeED. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal cancer. Ann Surg1976; 183: 5–9.
19.
StaabHJAndererFABrummendorfTPrognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma. Br J Cancer1981; 44: 652–62.
20.
GoslinRHSteeleGMacIntyreJThe use of preoperative CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg1980; 192: 747–51.
21.
MachJ-PViennyHJaegerPLong-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay. Cancer1978; 42, Suppl. 3: 1439–47.
22.
MintonJPMartinEW. The use of serial CEA determinations to predict recurrence of colon cancer and when to do a second-look operation. Cancer1978; 42: 1422–7.
23.
TateH.Plasma CEA in the post-surgical monitoring of colorectal carcinoma. Br J Cancer1982; 46: 323–30.
24.
WoodCBRatcliffeJGBurtRWThe clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg1980; 67: 46–8.
25.
GillPGMorrisPJ. The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg1978; 65: 17–20.
26.
WangensteenOHLewisFJArhelgerSWAn interim report upon the ‘second look' procedure for cancer of the stomach, colon and rectum and for ‘limited intraperitoneal carcinosis'. Surg Gynecol Obstet1954; 99: 257–67.
27.
MeekerWR. The use and abuse of CEA test in clinical practice. Cancer1978; 41: 854–62.
28.
AttiyehFFStearnsMW. Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer1981; 47: 2119–25.
29.
SteeleGZamcheckNWilsonRResults of CEA-initiated second-look surgery for recurrent colorectal cancer. Am J Surgery1980; 139: 544–8.
30.
MoertelCGSchuttAJGoVLW. CEA antigen test for recurrent colorectal carcinoma. JAMA1978; 239: 1065–6.
31.
GoldenbergDMDeLandFKimEUse of radiolabelled antibodies to CEA for the detection and localization of diverse cancers by external photoscanning. New Eng J Med1978; 298: 1384–6.
BronsteinBRSteeleGDEnsimingerWThe use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumour volume in patients receiving chemotherapy. Cancer1980; 46: 266–72.
34.
MayerRJGarnickMBSteeleGDCarcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer1978; 42: 1428–33.
35.
PoseyLEMorganLR. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel. Cancer Treat Rep1977; 61: 1453–8.
36.
Al-SarrafMBakerLTalleyRWThe value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy. Cancer1979; 44: 1222–5.
37.
HerreraMAChuTMHolyokeEDCEA monitoring of palliative treatment for colorectal carcinoma. Ann Surg1977; 185: 25–30.
38.
SugarbakerPHBloomerWDCorbettEDCarcinoembryonic antigen (CEA) monitoring of radiation therapy for colo-rectal cancer. Am J Roentgenol Radium Ther Nucl Med1976; 127: 641–4.
39.
HaagensonDEKisterSJVandevoordeJPEvaluation of carcioembryonic antigen as a plasma monitor for human breast carcinoma. Cancer1978; 42, Suppl. 3: 1512–19.
40.
CoombesRCPowlesTJGazetJ-CAssessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet1980; i: 296–7.
41.
ConcannonJPDalbrowMHHodgsonSEPronostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchial carcinoma. Cancer1978; 42, Suppl. 3: 1477–83.
42.
DentPBMcCullochPBWesley-JamesOMeasurements of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer1978; 42, Suppl. 3: 1484–91.
ZamcheckNMartinEW. Factors controlling the circulating CEA levels in pancreatic cancer: Some clinical correlations. Cancer1981; 47: 1620–7.
45.
AlexanderJCChretienPBDellonALCEA levels in patients with carcinoma of the esophagus. Cancer1978; 42, Suppl. 3: 1492–7.
46.
Van NagellJRDonaldsonESWoodEGThe clinical significance of carcinoembryonic antigen in the plasma and tumors of patients with gynecological malignancies. Cancer1978; 42, Suppl. 3: 1527–32.
47.
CoombesGBHallRRLaurenceDJRUrinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy. A clinical appraisal. Br J Cancer1975; 31: 135–42.
48.
WellsGAHaagensenDELinehanWNThe detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma. Cancer1978; 42, Suppl. 3: 1498–1503.
49.
CortesEPChawlaSReddyPCarcinoembryonic antigen (CEA) in extracellular fluid (ECF): Benign or malignant. Proc Amer Assoc Cancer Res1974; 15: 101.
50.
RittgersRALoewensteinMSFeinermanAECarcinoembryonic antigen levels in benign and malignant pleural effusions. Ann Int Med1978; 88: 631–4.
51.
LoewensteinMSRittgersRAFeinermanAECarcinoembryonic antigen assay of ascites and detection of malignancy. Ann Int Med1978; 88: 635–8.
52.
LoewensteinMSRittgersRAKupchikHZCarcinoembryonic antigen gradients between plasma and malignant ascites: Use in detecting peritoneal and liver metastases. J Natl Cancer Inst1981; 66: 803–6.
53.
ArdietCFontamiereBClavelMBreast cancer cerebro-meningeal metastases: A comparison of the diagnostic values of CEA determination and cytological examination of cerebro-spinal fluid. In: LehmanFD, ed. Carcinoembryonic ProteinsVol 2. Elsevier North-Holland Biomedical Press, 1979; 147–50.
54.
YapHYYapBSTashimaCKTreatment and prognostic factors for meningeal carcinomatosis in breast cancer. Proc Amer Soc Clin Oncol1979; 20: 93.
55.
GalenRS. The predictive value of laboratory diagnosis. Lab J Res Lab Med1979; vi: 37–46.